Showing results (1-10 of 1,665) with videos related to
Sort By:
Pageof 167
Clinical and Experimental Rheumatology|November 4, 2010
Perioperative use of methotrexateF Heldmann, J BraunZeitschrift Fur Rheumatologie|September 28, 2014
[SAPHO syndrome]F Heldmann, U Kiltz, X Baraliakos, et al.Zeitschrift Fur Rheumatologie|January 27, 2011
[Perioperative use of biologicals in rheumatoid arthritis]F Heldmann, F Dybowski, X Baraliakos, et al.Deutsche Medizinische Wochenschrift (1946)|December 24, 2005
[A 46-year-old-patient with granulomatous prostatitis, arthralgia and haemorrhagic rhinitis]F Heldmann, J Brandt, H Schoppe, et al.Der Internist|November 28, 2013
[What is ascertained in the therapy of axial spondyloarthritis?]J Braun, X Baraliakos, F Heldmann, et al.Zeitschrift Fur Rheumatologie|February 29, 2012
[Practical problems by implementation of vaccination recommendations]C Fendler, E Saracbasi, F Dybowski, et al.Annals of the Rheumatic Diseases|May 7, 2013
High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritisX Baraliakos, N Baerlecken, T Witte, et al.Deutsche Medizinische Wochenschrift (1946)|October 13, 2011
[Generalized osteoarthritis in a young adult with type II collagenopathy]F Dybowski, F Moos, E Saracbasi-Zender, et al.Annals of the Rheumatic Diseases|March 19, 2011
Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot studyI-H Song, F Heldmann, M Rudwaleit, et al.Arthritis and Rheumatism|May 13, 2010
Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trialI-H Song, F Heldmann, M Rudwaleit, et al.Pageof 167